- Home
- LCTX vs VIOT Comparison
LCTX vs VIOT Comparison
Compare LCTX & VIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCTX
- VIOT
- Stock Information
- Founded
- LCTX 1990
- VIOT 2014
- Country
- LCTX United States
- VIOT China
- Employees
- LCTX N/A
- VIOT N/A
- Industry
- LCTX Biotechnology: Biological Products (No Diagnostic Substances)
- VIOT Consumer Electronics/Appliances
- Sector
- LCTX Health Care
- VIOT Consumer Discretionary
- Exchange
- LCTX Nasdaq
- VIOT Nasdaq
- Market Cap
- LCTX 95.2M
- VIOT 92.8M
- IPO Year
- LCTX N/A
- VIOT 2018
- Fundamental
- Price
- LCTX $0.49
- VIOT $1.29
- Analyst Decision
- LCTX Strong Buy
- VIOT
- Analyst Count
- LCTX 5
- VIOT 0
- Target Price
- LCTX $4.20
- VIOT N/A
- AVG Volume (30 Days)
- LCTX 860.2K
- VIOT 112.0K
- Earning Date
- LCTX 05-13-2025
- VIOT 03-25-2025
- Dividend Yield
- LCTX N/A
- VIOT N/A
- EPS Growth
- LCTX N/A
- VIOT N/A
- EPS
- LCTX N/A
- VIOT 0.13
- Revenue
- LCTX $9,557,000.00
- VIOT $290,307,298.00
- Revenue This Year
- LCTX N/A
- VIOT $15.62
- Revenue Next Year
- LCTX $232.66
- VIOT $12.98
- P/E Ratio
- LCTX N/A
- VIOT $4.40
- Revenue Growth
- LCTX 19.42
- VIOT N/A
- 52 Week Low
- LCTX $0.37
- VIOT $0.50
- 52 Week High
- LCTX $1.40
- VIOT $2.38
- Technical
- Relative Strength Index (RSI)
- LCTX 54.19
- VIOT 39.74
- Support Level
- LCTX $0.45
- VIOT $1.28
- Resistance Level
- LCTX $0.49
- VIOT $1.41
- Average True Range (ATR)
- LCTX 0.03
- VIOT 0.09
- MACD
- LCTX 0.00
- VIOT 0.00
- Stochastic Oscillator
- LCTX 72.25
- VIOT 5.56
About LCTX Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
About VIOT Viomi Technology Co. Ltd
Viomi Technology Co Ltd along with its subsidiaries provides Internet of Things (IoT) enabled smart home products through its platform. It has developed an IoT Home platform, consisting of an ecosystem of IoT Home portfolio, and home water solutions, together with a suite of complementary consumable products and small appliances and others. Its product offerings include Smart kitchen products like refrigerators, oven steamers, dishwashers, and gas stoves, Other smart products such as air conditioning systems, washing machines, water heaters, smart water kettles, interactive smart screens and other smart devices, and Home water solutions include self-branded and Xiaomi-branded smart water purifiers.